Commercial Aviation

Business

Singapore's Green Flight Ambition Takes Off: Google, Airlines Join Landmark SAF Procurement Trial

A consortium of nine major corporations, including Google and Singapore Airlines, is launching a voluntary trial for centralized sustainable aviation fuel (SAF) procurement. This pilot, led by the newly formed SAFCo, is a critical step ahead of Singapore's pioneering green levy on departing flights set for October, aiming to refine systems for a 1% SAF usage target.

Feb 2, 2026

Business

Boeing's Record $682 Billion Order Backlog Signals Brighter Skies Ahead

While Boeing's Q4 revenue beat offers short-term relief, analysts point to its unprecedented order backlog as the true indicator of long-term recovery and growth potential in the commercial aviation sector.

Feb 2, 2026

Business

Textron's Defense Surge: Record Revenue and Ukraine Vehicle Contract Fuel Growth, But Questions on Sustainability Linger

Textron secures a major $163.4 million military contract while posting record annual revenue, driven by strength in Aviation and Bell. As its stock shows robust long-term gains, analysts debate whether this momentum is built to last.

Jan 30, 2026

Business

Analysts Bullish on Ardelyx Ahead of Q4 Earnings, Citing Blockbuster Potential for Key Drug

Ardelyx, Inc. (NASDAQ: ARDX) has received significant analyst upgrades, with TD Cowen and Jefferies raising price targets ahead of the company's fourth-quarter results. The optimism centers on the commercial trajectory of its flagship drug, tenapanor, for gastrointestinal and kidney conditions.

Feb 2, 2026

Business

Kura Oncology Eyes 2026 as Pivotal Year Amid Pipeline Expansion and Analyst Scrutiny

Following a price target adjustment by Leerink Partners, Kura Oncology (KURA) is drawing investor focus to its 2026 clinical milestones and commercial strategy for its newly launched AML drug, ziftomenib.

Feb 2, 2026

Business

Aon's Q4 Net Profit Soars 136% as Risk Business Drives Strong Performance

The global professional services firm Aon posted a net income of $1.7 billion for the final quarter of 2025, fueled by robust growth in its commercial risk and reinsurance divisions, while full-year revenue climbed 9% to $17.2 billion.

Feb 2, 2026

Business

First Merchants Navigates Rate Headwinds with Steady Loan Growth in Q4

Despite an 8.3% year-over-year revenue dip, First Merchants Corporation reported resilient fourth-quarter earnings, buoyed by disciplined deposit strategies and robust loan expansion. CEO Mark Hardwick pointed to strong commercial activity as a key driver, even as analysts probe the sustainability of growth and integration challenges ahead.

Feb 2, 2026

Business

WSFS Financial Caps Strong Year with Robust Q4, Analysts Probe Sustainability of Growth Drivers

WSFS Financial Corporation concluded its fiscal year with a powerful fourth quarter, fueled by strength in commercial lending and wealth management. As shares rally post-earnings, analysts are scrutinizing whether the bank can maintain its momentum amid evolving economic conditions.

Feb 2, 2026

Business

IonQ's Quantum Leap: Can the High-Flying Stock Justify Its Lofty Valuation?

IonQ, a pioneer in trapped-ion quantum computing, has seen its stock soar on the back of significant technical breakthroughs. Yet, with a valuation eclipsing established giants and a long road to commercial viability, investors face a high-stakes gamble between revolutionary potential and financial reality.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Business

Supply Chain Snarls and Geopolitical Strains Cloud Outlook at Singapore Airshow Summit

As the aviation industry gathers in Singapore, leaders confront persistent supply chain disruptions and shifting trade winds, even as they chart a course for sustainable growth in the world's fastest-growing travel market.

Feb 2, 2026

Business

D-Wave Quantum Bolsters Market Position with Dual-Platform Strategy and Major Florida Expansion

D-Wave Quantum solidifies its dual-platform quantum computing approach through the acquisition of Quantum Circuits Inc. and the launch of a major Florida R&D hub, backed by new multi-million dollar commercial and academic agreements.

Feb 2, 2026

Business

Allegion Doubles Down on Smart Security to Cement Institutional Market Position

Allegion (NYSE: ALLE) is accelerating its strategic shift toward integrated smart security platforms, emphasizing digital credentials, connected locks, and cloud-based access control to meet growing demand from commercial and institutional clients.

Feb 2, 2026

Business

BrightView Earnings Preview: Can the Landscaping Giant Stem Its Revenue Slide?

As BrightView Holdings prepares to report its fourth-quarter results, investors are watching closely to see if the commercial landscaping leader can halt a streak of revenue misses and navigate a challenging economic environment.

Feb 2, 2026

Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Feb 2, 2026

Business

Glaukos Gains FDA Nod for Repeat iDose TR Implant, Bolstering Its Long-Term Glaucoma Platform Strategy

The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.

Feb 2, 2026

Business

Mondelez Consolidates Power: CFO Luca Zaramella Takes Helm as COO Amid Scrutiny Over Costs and Growth

Mondelez International merges financial and operational oversight under veteran CFO Luca Zaramella, who assumes the additional role of Chief Operating Officer. The strategic move aims to tighten cost discipline across global commercial units but raises questions about succession planning and cash flow pressures as the snack giant navigates a challenging market.

Jan 31, 2026

Business

Deutsche Bank Hits 2025 Targets, Sets Sights on Higher Returns Amid Strategic Shift

Deutsche Bank reported meeting its key 2025 financial objectives, including a 10.3% return on tangible equity, and outlined a path to boost profitability above 13% by 2028. The update, delivered during a fixed income call, highlighted revenue growth, cost discipline, and a strengthened balance sheet, even as management signaled caution on parts of the commercial real estate market.

Jan 30, 2026

Business

First Business Financial Services Caps 2025 with Strong Quarter, Navigates Isolated CRE Challenge

First Business Financial Services (FBIZ) reported robust 2025 results, driven by resilient margins and core deposit growth, while detailing a contained credit issue in its commercial real estate portfolio and outlining double-digit growth targets for the coming year.

Jan 30, 2026

Business

Rigetti Computing Stock Upgraded to 'Buy' by B. Riley Following Major Quantum Computer Order from India

B. Riley analyst Craig Ellis has upgraded Rigetti Computing (NASDAQ: RGTI) from 'Neutral' to 'Buy', maintaining a $35 price target. The upgrade follows the company's announcement of an $8.4 million order to supply a 108-qubit quantum computer to India's premier R&D agency, C-DAC, providing clearer visibility into its 2026 commercial trajectory.

Jan 30, 2026